Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/23/2025

Hepatitis B Surface Antigen Testing

Introduction to HBsAg

  • The Centers for Disease Control and Prevention recommends that HBsAg is a serological marker that indicates current HBV infection, either acute or chronic, and confirms that the person is infectious 1, 2

What HBsAg Measures

  • HBsAg is a multifunctional glycoprotein on the surface of the hepatitis B virus that serves as the hallmark of HBV infection 1, 2
  • It is the first serological marker to appear in acute hepatitis B infection, typically detectable 1-10 weeks before the onset of symptoms 2
  • A positive HBsAg test indicates active HBV infection and infectiousness of the individual 1, 2
  • If HBsAg persists for more than 6 months, the infection is considered chronic, as spontaneous clearance becomes unlikely 1

Clinical Significance of HBsAg

  • Positive HBsAg confirms the diagnosis of current HBV infection (acute or chronic) 1, 3
  • All HBsAg-positive individuals are considered infectious and capable of transmitting the virus 2
  • HBsAg can be detected prior to the appearance of symptoms and other serological markers in acute infection 1
  • Persistence of HBsAg beyond 6 months indicates progression to chronic HBV infection 1, 2
  • Transient HBsAg positivity can occur up to 18 days following vaccination (up to 52 days in hemodialysis patients) and is clinically insignificant 1

Interpretation in Context with Other Markers

  • HBsAg results should be interpreted alongside other serological markers for complete understanding of infection status, with the following combinations:
    • HBsAg positive + Total anti-HBc positive + IgM anti-HBc positive = Acute HBV infection 1, 4
    • HBsAg positive + Total anti-HBc positive + IgM anti-HBc negative = Chronic HBV infection 1, 4
    • HBsAg negative + Total anti-HBc positive + Anti-HBs positive = Resolved HBV infection with immunity 1, 4
    • HBsAg negative + Anti-HBc negative + Anti-HBs positive = Immunity from vaccination 1
    • HBsAg negative + Anti-HBc negative + Anti-HBs negative = Never infected, susceptible to infection 1

Special Considerations

  • Occult HBV infection can occur when HBsAg is undetectable despite the presence of HBV DNA in serum or liver tissue 1
  • Some chronically infected individuals with isolated anti-HBc positivity may have circulating HBsAg that is not detectable by standard laboratory assays 1
  • In perinatal HBV infection, a positive HBsAg test in an infant born to an HBV-infected mother indicates infection if timing criteria are met 1
  • HBV DNA can be detected prior to the detection of HBsAg in an infected person 2

Clinical Applications

  • HBsAg testing is essential for diagnosis of acute and chronic HBV infection 3
  • It is used for screening high-risk populations, pregnant women, and blood donors 5
  • HBsAg testing is critical for identifying individuals who require further evaluation, monitoring, and potential treatment 5

Limitations

  • HBsAg may not be detectable in occult HBV infection despite ongoing viral replication 1
  • Transient HBsAg positivity after vaccination can lead to false-positive results 1
  • Additional testing (HBV DNA, other serological markers) may be needed for complete assessment of infection status 3